Costs and benefits of dose-dense chemotherapy scheduling in Hong Kong Chinese patients with primary breast cancer

被引：0
|
作者：
Tsang, J.
Yau, T.
Chan, A. T.
Liang, R. H.
Yeo, W.
Epstein, R. J.
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11054
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dose-dense chemotherapy in nonmetastatic breast cancer patients: A systematic review and meta-analysis
    Bonilla, L. F.
    Ben-Aharon, I.
    Vidal, L.
    Gafter-Gvili, A.
    Leibovici, L.
    Stemmer, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study
    Clavarezza, Matteo
    Bordonaro, Roberto
    Daniele, Bruno
    Ferrandina, Gabriella
    Barni, Sandro
    Turazza, monica
    Coati, Francesca
    De Matteis, Andrea
    De Placido, Sabino
    Cognetti, Francesco
    Olmeo, Nina Antonina
    Carrozza, Francesco
    Bruzzi, Paolo
    Del Mastro, Lucia
    ONCOLOGIST, 2013, 18 (08): : 924 - 925
  • [43] Efficacy and safety of perioperative dose-dense chemotherapy for breast cancer patients, including elderly population
    Ishiguro, Atsushi
    Tanimoto, Aya
    Ito, Keiichiro
    Ohigashi, An
    ANNALS OF ONCOLOGY, 2021, 32 : S303 - S303
  • [44] Rituximab and Dose-Dense Chemotherapy in Primary Testicular Lymphoma
    Aviles, Agustin
    Jesus Nambo, M.
    Cleto, Sergio
    Neri, Natividad
    Huerta-Guzman, Judith
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (05): : 386 - 389
  • [45] Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide → dose-dense docetaxel
    Cocciolone, V.
    Tessitore, A.
    Ricevuto, E.
    Mastroiaco, V.
    Rinaldi, L.
    Paradisi, S.
    Irelli, A.
    Sidoni, T.
    Dal Mas, A.
    Coletti, G.
    Ciccozzi, A.
    Resta, V.
    Bafile, A.
    Alesse, E.
    Ficorella, C.
    Cannita, K.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S124 - S124
  • [46] Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
    Zauderer, Marjorie
    Patil, Sujata
    Hurria, Arti
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (01) : 205 - 210
  • [47] Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer
    Metzger Filho, Otto
    Ballman, Karla
    Campbell, Jordan
    Liu, Minetta
    Ligibel, Jennifer
    Watson, Mark
    Chen, Eveline
    Du, Lili
    Stover, Daniel
    Carey, Lisa
    Partridge, Ann
    Kirshner, Jeffrey
    Muss, Hyman
    Hudis, Clifford
    Winer, Eric P.
    Norton, Larry
    Symmans, W. Fraser
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (10)
  • [48] Adjuvant Dose-Dense Chemotherapy for Breast Cancer: Available Evidence and Recent Updates
    de Almeida, Fernando Kude
    Rosa, Daniela Dornelles
    BREAST CARE, 2018, 13 (06) : 447 - 452
  • [49] Role of dose-dense chemotherapy in high-risk early breast cancer
    Blondeaux, Eva
    Poggio, Francesca
    Del Mastro, Lucia
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (06) : 480 - 485
  • [50] Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
    Marjorie Zauderer
    Sujata Patil
    Arti Hurria
    Breast Cancer Research and Treatment, 2009, 117
12345